Jan 10, 2023 / 12:30AM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Perfect. Hi, everyone. This is Rachel Vatnsdal with the Life Science Tools Diagnostics team. I'm joined by Udit Batra today, CEO of Waters. And so as a reminder, this will be a standard presentation. So we'll do a 20-minute presentation, followed by Q&A. You are able to submit questions via that conference portal if you're watching via webcast. Otherwise, if you're in person, feel free to raise your hand. We do have mic runners. We just ask that you wait to ask your question until you have the mic. So with that, Udit?
Udit Batra - Waters Corporation - President, CEO & Director
Thank you, Rachel. Good afternoon, everyone, and thank you for braving the day and staying for one of the last presentations during the day. I hope to keep it entertaining for you. Roughly 2 years ago or so, we launched our transformation program, which we announced almost 2 years ago at this conference, and I hope to be able to provide you an update on where we are with that transformation. Nothing
Waters Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot